Teva to Buy Auspex, an American Drug Developer, for $3.2 Billion by DAVID GELLES

By DAVID GELLES

Teva will pay $101 a share for Auspex, which makes drugs that treat people with movement disorders.

Published: March 31, 2015 at 12:00AM

from NYT Business Day http://ift.tt/1NyhV8X

from WordPress http://ift.tt/1GGKM99

via Hadi Aboukhater